Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ENCAPSULATED DOXORUBICIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 48 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Swenson, CE; Perkins, WR; Roberts, P; Janoff, AS
      Liposome technology and the development of Myocet (TM) (liposomal doxorubicin citrate)

      BREAST
    2. Schmid, P; Possinger, K
      Liposomal anthracyclines for improved cardiac tolerability

      BREAST
    3. Matsuda, I; Konno, H; Tanaka, T; Nakamura, S
      Antimetastatic effect of hepatotropic liposomal adriamycin on human metastatic liver tumors

      SURGERY TODAY
    4. Iarussi, D; Indolfi, P; Casale, F; Coppolino, P; Tedesco, MA; Di Tullio, MT
      Recent advances in the prevention of anthracycline cardiotoxicity in childhood

      CURRENT MEDICINAL CHEMISTRY
    5. Vogel, CL
      Systemic therapy for older women with breast cancer - The Kimmick/Muss article reviewed

      ONCOLOGY-NEW YORK
    6. Bellott, R; Auvrignon, A; Leblanc, T; Perel, Y; Gandemer, V; Bertrand, Y; Mechinaud, F; Bellenger, P; Vernois, J; Leverger, G; Baruchel, A; Robert, J
      Pharmacokinetics of liposomal daunorubicin [DaunoXome] during a phase I-IIstudy in children with relapsed acute lymphoblastic leukaemia

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    7. Sparano, JA; Winer, EP
      Liposomal anthracyclines for breast cancer

      SEMINARS IN ONCOLOGY
    8. Burstein, HJ; Bunnell, CA; Winer, EP
      New cytotoxic agents and schedules for advanced breast cancer

      SEMINARS IN ONCOLOGY
    9. Hong, RL; Tseng, YL
      Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors - The relation between pharmacokinetic property and toxicity

      CANCER
    10. El-Kareh, AW; Secomb, TW
      A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells

      NEOPLASIA
    11. Wolff, AC
      Systemic therapy

      CURRENT OPINION IN ONCOLOGY
    12. Harrington, KJ; Lewanski, CR; Stewart, JSW
      Liposomes as vehicles for targeted therapy of cancer. Part 2: Clinical development

      CLINICAL ONCOLOGY
    13. Safra, T; Muggia, F; Jeffers, S; Tsao-Wei, DD; Groshen, S; Lyass, O; Henderson, R; Berry, G; Gabizon, A
      Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m(2)

      ANNALS OF ONCOLOGY
    14. Dams, ETM; Laverman, P; Oyen, WJG; Storm, G; Scherphof, GL; Van der Meer, JWM; Corstens, FHM; Boerman, OC
      Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    15. Hong, RL; Huang, CJ; Tseng, YL; Pang, VF; Chen, ST; Liu, JJ; Chang, FH
      Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial?

      CLINICAL CANCER RESEARCH
    16. Wang, YY; Eksborg, S; Lewensohn, R; Lindberg, A; Liliemark, E
      In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulations of daunorubicin and doxorubicin in resistant K562 cells

      ANTI-CANCER DRUGS
    17. Zucchetti, M; Boiardi, A; Silvani, A; Parisi, I; Piccolrovazzi, S; D'Incalci, M
      Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    18. Terwogt, JMM; Schellens, JHM; Huinink, WWT; Beijnen, JH
      Clinical pharmacology of anticancer agents in relation to formulations andadministration routes

      CANCER TREATMENT REVIEWS
    19. Poujol, S; Tilleul, P; Astre, C; Martel, P; Fabbro, M; Pinguet, F
      Effect of mitoxantrone liposomes on multidrug-resistant breast cancer cells

      ANTICANCER RESEARCH
    20. Klimuk, SK; Semple, SC; Scherrer, P; Hope, MJ
      Contact hypersensitivity: a simple model for the characterization of disease-site targeting by liposomes

      BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    21. SALLOVITZ JM; MENGHINI MIZ; LANUSSE CE
      IMPACT OF LIPOSOMES AS DELIVERY SYSTEMS IN VETERINARY-MEDICINE

      Veterinary research
    22. JOHNSON SA; RICHARDSON DS
      ANTHRACYCLINES IN HEMATOLOGY - PHARMACOKINETICS AND CLINICAL-STUDIES

      Blood reviews
    23. LASIC DD
      NOVEL APPLICATIONS OF LIPOSOMES

      Trends in biotechnology
    24. ALLEN TM
      LIPOSOMAL DRUG FORMULATIONS - RATIONALE FOR DEVELOPMENT AND WHAT WE CAN EXPECT FOR THE FUTURE

      Drugs
    25. Newell, M; Milliken, S; Goldstein, D; Lewis, C; Boyle, M; Dolan, G; Ryan, S; Cooper, DA
      A phase II study of liposomal doxorubicin in the treatment of HIV-related Kaposi's sarcoma

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE
    26. RANSON MR; CARMICHAEL J; OBYRNE K; STEWART S; SMITH D; HOWELL A
      TREATMENT OF ADVANCED BREAST-CANCER WITH STERICALLY STABILIZED LIPOSOMAL DOXORUBICIN - RESULTS OF A MULTICENTER PHASE-II TRIAL

      Journal of clinical oncology
    27. CULLIS PR; HOPE MJ; BALLY MB; MADDEN TD; MAYER LD; FENSKE DB
      INFLUENCE OF PH GRADIENTS ON THE TRANSBILAYER TRANSPORT OF DRUGS, LIPIDS, PEPTIDES AND METAL-IONS INTO LARGE UNILAMELLAR VESICLES

      Biochimica et biophysica acta, MR. Reviews on biomembranes
    28. KONNO H; MARUO Y; MATSUDA I; TANAKA T; BABA S
      APPLICATION OF LIPOSOMES TO THE TREATMENT OF LIVER METASTASIS

      Advanced drug delivery reviews
    29. KROWN SE
      ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED KAPOSIS-SARCOMA - BIOLOGY AND MANAGEMENT

      The Medical clinics of North America
    30. ALLEN TM
      LIPOSOMES - OPPORTUNITIES IN DRUG-DELIVERY

      Drugs
    31. COUKELL AJ; SPENCER CM
      POLYETHYLENE GLYCOL-LIPOSOMAL DOXORUBICIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THEMANAGEMENT OF AIDS-RELATED KAPOSIS-SARCOMA

      Drugs
    32. TARDI PG; BOMAN NL; CULLIS PR
      LIPOSOMAL DOXORUBICIN

      Journal of drug targeting.
    33. LEE FC; MITSUYASU RT
      CHEMOTHERAPY OF AIDS-RELATED KAPOSIS-SARCOMA

      Hematology/oncology clinics of North America
    34. JONKMANDEVRIES JD; FLORA KP; BULT A; BEIJNEN JH
      PHARMACEUTICAL DEVELOPMENT OF (INVESTIGATIONAL) ANTICANCER AGENTS FORPARENTERAL USE - A REVIEW

      Drug development and industrial pharmacy
    35. RANSON M; HOWELL A; CHEESEMAN S; MARGISON J
      LIPOSOMAL DRUG-DELIVERY

      Cancer treatment reviews
    36. BOSCH I; CROOP J
      P-GLYCOPROTEIN MULTIDRUG-RESISTANCE AND CANCER

      Biochimica et biophysica acta, CR. Reviews on cancer
    37. UZIELY B; JEFFERS S; ISACSON R; KUTSCH K; WEITSAO D; YEHOSHUA Z; LIBSON E; MUGGIA FM; GABIZON A
      LIPOSOMAL DOXORUBICIN - ANTITUMOR-ACTIVITY AND UNIQUE TOXICITIES DURING 2 COMPLEMENTARY PHASE-I STUDIES

      Journal of clinical oncology
    38. GILL PS; ESPINA BM; MUGGIA F; CABRIALES S; TULPULE A; ESPLIN JA; LIEBMAN HA; FORSSEN E; ROSS ME; LEVINE AM
      PHASE I II CLINICAL AND PHARMACOKINETIC EVALUATION OF LIPOSOMAL DAUNORUBICIN/

      Journal of clinical oncology
    39. SCHWARTZ GK; GASPER ES
      A PHASE-II TRIAL OF DOXORUBICIN HCL LIPOSOME INJECTION IN PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA

      Investigational new drugs
    40. KONNO H; MARUO Y; MATSUDA I; NAKAMURA S; BABA S
      INTRAARTERIAL LIPOSOMAL ADRIAMYCIN FOR METASTATIC ADENOCARCINOMA OF THE LIVER

      European surgical research
    41. SELA S; HUSAIN SR; PEARSON JW; LONGO DL; RAHMAN A
      REVERSAL OF MULTIDRUG-RESISTANCE IN HUMAN COLON-CANCER CELLS EXPRESSING THE HUMAN MDR1 GENE BY LIPOSOMES IN COMBINATION WITH MONOCLONAL-ANTIBODY OR VERAPAMIL

      Journal of the National Cancer Institute
    42. GABIZON AA
      LIPOSOMAL ANTHRACYCLINES

      Hematology/oncology clinics of North America
    43. LAW TM; MENCEL P; MOTZER RJ
      PHASE-II TRIAL OF LIPOSOMAL ENCAPSULATED DOXORUBICIN IN PATIENTS WITHADVANCED RENAL-CELL CARCINOMA

      Investigational new drugs
    44. GUAGLIANONE P; CHAN K; DELAFLORWEISS E; HANISCH R; JEFFERS S; SHARMA D; MUGGIA F
      PHASE-I AND PHARMACOLOGICAL STUDY OF LIPOSOMAL DAUNORUBICIN (DAUNOXOME)

      Investigational new drugs
    45. BOOSER DJ; HORTOBAGYI GN
      ANTHRACYCLINE ANTIBIOTICS IN CANCER-THERAPY - FOCUS ON DRUG-RESISTANCE

      Drugs
    46. DELAFLORWEISS E; UZIELY B; MUGGIA FM
      PROTRACTED DRUG INFUSIONS IN CANCER-TREATMENT - AN APPRAISAL OF 5-FLUOROURACIL, DOXORUBICIN, AND PLATINUMS

      Annals of oncology
    47. ROBERT J; GIANNI L
      PHARMACOKINETICS AND METABOLISM OF ANTHRACYCLINES

      Cancer surveys
    48. CODDE JP; LUMSDEN AJ; NAPOLI S; BURTON MA; GRAY BN
      A COMPARATIVE-STUDY OF THE ANTICANCER EFFICACY OF DOXORUBICIN CARRYING MICROSPHERES AND LIPOSOMES USING A RAT-LIVER TUMOR-MODEL

      Anticancer research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 19:41:09